Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease-19 (COVID-19): A scoping review
- PMID: 33990972
- PMCID: PMC8242919
- DOI: 10.1002/jmv.27081
Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease-19 (COVID-19): A scoping review
Abstract
The human immune system is not adequately equipped to eliminate new microbes and could result in serious damage on first exposure. This is primarily attributed to the exaggerated immune response (inflammatory disease), which may prove detrimental to the host, as evidenced by SARS-CoV-2 infection. From the experiences of Novel Coronavirus Disease-19 to date, male patients are likely to suffer from high-intensity inflammation and disease severity than the female population. Hormones are considered the significant pillars of sex differences responsible for the discrepancy in immune response exhibited by males and females. Females appear to be better equipped to counter invading respiratory viral pathogens, including the novel SARS-CoV-2, than males. It can be hypothesized that females are more shielded from disease severity, probably owing to the diverse action/influence of estrogen and other sex hormones on both cellular (thymus-derived T lymphocytes) and humoral immunity (antibodies).
Keywords: COVID-19; SARS-CoV-2; estrogen; gender biasness; immune system; inflammation; sex hormones.
© 2021 Wiley Periodicals LLC.
Conflict of interest statement
The authors declare that there are no conflict of interests.
Figures




Similar articles
-
Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones.Am J Physiol Heart Circ Physiol. 2021 Jan 1;320(1):H296-H304. doi: 10.1152/ajpheart.00755.2020. Epub 2020 Dec 4. Am J Physiol Heart Circ Physiol. 2021. PMID: 33275517 Free PMC article. Review.
-
Sex-related susceptibility in coronavirus disease 2019 (COVID-19): Proposed mechanisms.Eur J Pharmacol. 2021 Dec 5;912:174548. doi: 10.1016/j.ejphar.2021.174548. Epub 2021 Oct 2. Eur J Pharmacol. 2021. PMID: 34606834 Free PMC article.
-
Immuno-Endocrinology of COVID-19: The Key Role of Sex Hormones.Front Endocrinol (Lausanne). 2021 Dec 2;12:726696. doi: 10.3389/fendo.2021.726696. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34925228 Free PMC article. Review.
-
Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection.J Adv Res. 2021 Jul;31:49-60. doi: 10.1016/j.jare.2020.12.013. Epub 2021 Jan 5. J Adv Res. 2021. PMID: 33520309 Free PMC article. Review.
-
Sex Disparities in COVID-19 Severity and Outcome: Are Men Weaker or Women Stronger?Neuroendocrinology. 2021;111(11):1066-1085. doi: 10.1159/000513346. Epub 2020 Nov 26. Neuroendocrinology. 2021. PMID: 33242856 Free PMC article. Review.
Cited by
-
The Suppressor of Cytokine Signalling family of proteins and their potential impact on COVID-19 disease progression.Rev Med Virol. 2022 May;32(3):e2300. doi: 10.1002/rmv.2300. Epub 2021 Sep 21. Rev Med Virol. 2022. PMID: 34546610 Free PMC article. Review.
-
Mucociliary clearance affected by mucus-periciliary interface stimulations using analytical solution during cough and sneeze.Eur Phys J Plus. 2023;138(3):201. doi: 10.1140/epjp/s13360-023-03796-7. Epub 2023 Mar 3. Eur Phys J Plus. 2023. PMID: 36883183 Free PMC article.
-
Long Covid: Untangling the Complex Syndrome and the Search for Therapeutics.Viruses. 2022 Dec 22;15(1):42. doi: 10.3390/v15010042. Viruses. 2022. PMID: 36680082 Free PMC article. Review.
-
Testosterone in males with COVID-19: A 7-month cohort study.Andrology. 2022 Jan;10(1):34-41. doi: 10.1111/andr.13097. Epub 2021 Aug 31. Andrology. 2022. PMID: 34409772 Free PMC article.
-
Negative association between ascaris lumbricoides seropositivity and Covid-19 severity: insights from a study in Benin.Front Immunol. 2023 Aug 9;14:1233082. doi: 10.3389/fimmu.2023.1233082. eCollection 2023. Front Immunol. 2023. PMID: 37622109 Free PMC article.
References
-
- Kusel MM, de Klerk NH, Holt PG, Kebadze T, Johnston SL, Sly PD. Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study. Pediatr Infect Dis J. 2006;25:680‐686. - PubMed
-
- Mohapatra RK, Perekhoda L, Azam M, et al. Computational investigations of three main drugs and their comparison with synthesized compounds as potent inhibitors of SARS‐CoV‐2 main protease (Mpro): DFT, QSAR, molecular docking, and in silico toxicity analysis. J. King Saud Univ.–Sci. 2021;33:101315. - PMC - PubMed
-
- Mohapatra RK, Das PK, Pintilie L, Dhama K. Infection capability of SARS‐CoV‐2 on different surfaces. Egypt J Basic Appl Sci. 2021;8(1):75‐80.
-
- Arumugam VA, Thangavelu S, Fathah Z, et al. COVID‐19 and the world with co‐morbidities of heart disease, hypertension and diabetes. J Pure Appl Microbiol. 2020;14(3):1623‐1638.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous